Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Diabetic Foot Ulcer (DFU) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Wound Care Dressings
1.4.3 Biologics
1.4.4 Therapy Devices
1.4.5 Antibiotic Medications
1.4.6 Others
1.5 Market by Application
1.5.1 Global Diabetic Foot Ulcer (DFU) Treatment Market Share by Application (2019-2025)
1.5.2 Neuropathic Ulcers
1.5.3 Ischemic Ulcers
1.5.4 Neuro-ischemic Ulcers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Diabetic Foot Ulcer (DFU) Treatment Market Size
2.2 Diabetic Foot Ulcer (DFU) Treatment Growth Trends by Regions
2.2.1 Diabetic Foot Ulcer (DFU) Treatment Market Size by Regions (2019-2025)
2.2.2 Diabetic Foot Ulcer (DFU) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Diabetic Foot Ulcer (DFU) Treatment Market Size by by Players
3.1.1 Global Diabetic Foot Ulcer (DFU) Treatment Revenue by by Players (2014-2019)
3.1.2 Global Diabetic Foot Ulcer (DFU) Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Diabetic Foot Ulcer (DFU) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Diabetic Foot Ulcer (DFU) Treatment Key Players Head office and Area Served
3.3 Key Players Diabetic Foot Ulcer (DFU) Treatment Product/Solution/Service
3.4 Date of Enter into Diabetic Foot Ulcer (DFU) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Diabetic Foot Ulcer (DFU) Treatment Market Size by Type (2014-2019)
4.2 Global Diabetic Foot Ulcer (DFU) Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
5.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in North America
5.3 North America Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
5.4 North America Diabetic Foot Ulcer (DFU) Treatment Market Size by Application
6 Europe
6.1 Europe Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
6.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in Europe
6.3 Europe Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
6.4 Europe Diabetic Foot Ulcer (DFU) Treatment Market Size by Application
7 China
7.1 China Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
7.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in China
7.3 China Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
7.4 China Diabetic Foot Ulcer (DFU) Treatment Market Size by Application
8 Japan
8.1 Japan Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
8.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in Japan
8.3 Japan Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
8.4 Japan Diabetic Foot Ulcer (DFU) Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
9.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
9.4 Southeast Asia Diabetic Foot Ulcer (DFU) Treatment Market Size by Application
10 India
10.1 India Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
10.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in India
10.3 India Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
10.4 India Diabetic Foot Ulcer (DFU) Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
11.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in Central & South America
11.3 Central & South America Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
11.4 Central & South America Diabetic Foot Ulcer (DFU) Treatment Market Size by Application
12 International Players Profiles
12.1 ConvaTec
12.1.1 ConvaTec Company Details
12.1.2 Company Description and Business Overview
12.1.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.1.4 ConvaTec Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019))
12.1.5 ConvaTec Recent Development
12.2 Acelity
12.2.1 Acelity Company Details
12.2.2 Company Description and Business Overview
12.2.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.2.4 Acelity Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.2.5 Acelity Recent Development
12.3 Coloplast
12.3.1 Coloplast Company Details
12.3.2 Company Description and Business Overview
12.3.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.3.4 Coloplast Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.3.5 Coloplast Recent Development
12.4 3 M
12.4.1 3 M Company Details
12.4.2 Company Description and Business Overview
12.4.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.4.4 3 M Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.4.5 3 M Recent Development
12.5 Smith & Nephew
12.5.1 Smith & Nephew Company Details
12.5.2 Company Description and Business Overview
12.5.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.5.4 Smith & Nephew Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.5.5 Smith & Nephew Recent Development
12.6 B. Braun
12.6.1 B. Braun Company Details
12.6.2 Company Description and Business Overview
12.6.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.6.4 B. Braun Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.6.5 B. Braun Recent Development
12.7 Medline
12.7.1 Medline Company Details
12.7.2 Company Description and Business Overview
12.7.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.7.4 Medline Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.7.5 Medline Recent Development
12.8 Medtronic
12.8.1 Medtronic Company Details
12.8.2 Company Description and Business Overview
12.8.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.8.4 Medtronic Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.8.5 Medtronic Recent Development
12.9 Organogenesis
12.9.1 Organogenesis Company Details
12.9.2 Company Description and Business Overview
12.9.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.9.4 Organogenesis Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.9.5 Organogenesis Recent Development
12.10 Molnlycke Health Care
12.10.1 Molnlycke Health Care Company Details
12.10.2 Company Description and Business Overview
12.10.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.10.4 Molnlycke Health Care Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.10.5 Molnlycke Health Care Recent Development
12.11 BSN Medical
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
【掲載企業】
ConvaTec、Acelity、Coloplast、3 M、Smith & Nephew、B. Braun、Medline、Medtronic、Organogenesis、Molnlycke Health Care、BSN Medical
【免責事項】
https://www.globalresearch.jp/disclaimer